Safety and Efficacy of AGN-199201 and AGN-190584 in Patients With Presbyopia

NCT02197806 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

65

Enrollment

INDUSTRY

Sponsor class

Conditions

Presbyopia

Interventions

DRUG: AGN-199201
DRUG: AGN-190584
DRUG: AGN-199201 Vehicle

Sponsor

Allergan